NCT04170231 Bleeding in Critically Ill Children With Underlying Oncologic Diagnoses Status COMPLETED Phase N/A
NCT04169503 Immune Checkpoint Inhibitors Rechallenge After Immune-related Adverse Events Status UNKNOWN Phase N/A
NCT04162717 The Effect of Telephone Symptom Triage Protocols in Patients With Cancer Therapy (TeleTRIAGE) Status COMPLETED Phase NA
NCT04161885 A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML) Status TERMINATED Phase PHASE3
NCT04151342 CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS) Status RECRUITING Phase N/A
NCT04142710 Pragmatic Randomized Control Trial of Telehealth vs Standard Care in Follow-up of Patients With Chronic Conditions Status COMPLETED Phase NA
NCT04141462 EXOME Analysis Position in the Strategy of Genetic Predisposition Factors Identification in Early-onset Cancer Status RECRUITING Phase NA
NCT04138095 Virtual Reality as an Adjunct to Management of Pain and Anxiety in Palliative Care Status UNKNOWN Phase NA
NCT04136340 Supportive Care Delivered by Telemedicine to Cancer Patients at Home Status COMPLETED Phase NA
NCT04136249 Improvement of Neuromuscular Function, Fatigue and Quality of Life by Optimizing Muscle Building and Nutrition in Colorectal Cancer: a Pilot Study Status UNKNOWN Phase NA
NCT04135794 Magnetic Resonance-Guided Adaptive Radiotherapy (MRgART) Using an Integrated Magnetic Resonance Linear Accelerator (MRL) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04132856 Mapping Psychosocial Screening to Services for Children With Cancer Status COMPLETED Phase NA
NCT04130542 Phase 1 Trial of LVGN6051 as Single Agent and in Combination With Keytruda (Pembrolizumab) in Advanced or Metastatic Malignancy Status COMPLETED Phase PHASE1
NCT04128865 PRevention of INteractions Between Phytotherapies and CancEr Treatments by a SmartphonE/Tablet Automated SurvEy Status UNKNOWN Phase N/A
NCT04125693 Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its Safety Status COMPLETED Phase PHASE2